Completed
24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
NCT01989468
- Conditions
- Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
- Locations
-
- Novartis Investigative Site Aventura, Florida, United States
- Novartis Investigative Site Palm Harbor, Florida, United States
- Novartis Investigative Site Sarasota, Florida, United States
- Novartis Investigative Site Indianapolis, Indiana, United States